VIG
WST icon

Vienna Insurance Group’s West Pharmaceutical WST Stock Holding History

Vienna Insurance Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,790
Closed -$829K – 93
2025
Q2 		$829K Buy
3,790
+598
+19% +$128K 0.52% 63
2025
Q1 		$715K Sell
3,192
-415
-12% -$114K 0.39% 91
2024
Q4 		$1.18M Sell
3,607
-479
-12% -$151K 0.69% 38
2024
Q3 		$1.23M Buy
4,086
+724
+22% +$222K 0.52% 89
2024
Q2 		$1.11M Sell
3,362
-265
-7% -$93.7K 0.43% 92
2024
Q1 		$1.44M Buy
3,627
+500
+16% +$185K 0.56% 46
2023
Q4 		$1.1M Sell
3,127
-1,643
-34% -$581K 0.51% 87
2023
Q3 		$1.79M Buy
4,770
+958
+25% +$370K 0.8% 31
2023
Q2 		$1.46M Buy
3,812
+889
+30% +$318K 0.68% 46
2023
Q1 		$1.01M Buy
+2,923
New +$854K 0.59% 23

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Vienna Insurance Group's WST Position: Q3 2025 in Review

Vienna Insurance Group sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 3,790 shares — an estimated $829K sold.

Vienna Insurance Group first reported a position in WST in Q1 2023 and held it in 10 quarters. The position peaked at $1.79M in Q3 2023. 757 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Vienna Insurance Group reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Vienna Insurance Group sold 3,790 West Pharmaceutical shares in Q3 2025, an estimated $829K.
  • Vienna Insurance Group first reported a position in West Pharmaceutical in Q1 2023 and held it in 10 quarters.
  • Vienna Insurance Group's West Pharmaceutical position peaked at $1.79M in Q3 2023.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Vienna Insurance Group's 13F filing for Q3 2025, filed 3 Nov 2025.